CAM
AMGN icon

Cresset Asset Management’s Amgen AMGN Stock Holding History

Cresset Asset Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.1M Sell
45,854
-500
-1% -$178K 0.07% 185
2025
Q4 		$15.2M Buy
46,354
+216
+0.5% +$68.5K 0.06% 189
2025
Q3 		$13M Buy
46,138
+731
+2% +$212K 0.06% 200
2025
Q2 		$12.7M Sell
45,407
-5,535
-11% -$1.57M 0.06% 186
2025
Q1 		$15.9M Sell
50,942
-954
-2% -$282K 0.08% 158
2024
Q4 		$13.5M Sell
51,896
-33,170
-39% -$9.84M 0.06% 188
2024
Q3 		$27.4M Buy
85,066
+3,192
+4% +$1.04M 0.11% 130
2024
Q2 		$25.6M Buy
81,874
+12,394
+18% +$3.64M 0.11% 126
2024
Q1 		$19.8M Buy
69,480
+2,077
+3% +$608K 0.1% 147
2023
Q4 		$19.4M Sell
67,403
-137
-0.2% -$37.3K 0.12% 124
2023
Q3 		$18.2M Buy
67,540
+4,067
+6% +$1.01M 0.07% 139
2023
Q2 		$14.1M Buy
63,473
+51,313
+422% +$11.9M 0.02% 212
2023
Q1 		$2.94M Sell
12,160
-1,879
-13% -$461K 0.06% 181
2022
Q4 		$3.23M Sell
14,039
-503
-3% -$135K 0.04% 157
2022
Q3 		$3.28M Sell
14,542
-2,274
-14% -$551K 0.04% 163
2022
Q2 		$4.07M Sell
16,816
-3,154
-16% -$773K 0.05% 142
2022
Q1 		$4.83M Sell
19,970
-3,292
-14% -$756K 0.05% 130
2021
Q4 		$5.23M Sell
23,262
-8,349
-26% -$1.76M 0.05% 137
2021
Q3 		$6.72M Buy
31,611
+3,216
+11% +$740K 0.09% 95
2021
Q2 		$6.92M Sell
28,395
-138
-0.5% -$33.9K 0.1% 83
2021
Q1 		$7.1M Buy
28,533
+1,124
+4% +$268K 0.11% 75
2020
Q4 		$6.3M Sell
27,409
-8,445
-24% -$1.95M 0.1% 75
2020
Q3 		$9.11M Sell
35,854
-1,333
-4% -$330K 0.17% 59
2020
Q2 		$8.77M Sell
37,187
-439
-1% -$100K 0.19% 50
2020
Q1 		$7.63M Sell
37,626
-3,993
-10% -$872K 0.23% 38
2019
Q4 		$10M Sell
41,619
-5,921
-12% -$1.31M 0.27% 33
2019
Q3 		$9.2M Buy
47,540
+34,270
+258% +$6.58M 0.28% 40
2019
Q2 		$2.44M Sell
13,270
-44,810
-77% -$8.02M 0.08% 108
2019
Q1 		$2.41M Buy
58,080
+54,174
+1,387% +$10.3M 0.09% 55
2018
Q4 		$760K Buy
+3,906
New +$762K 0.05% 91

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Cresset Asset Management's AMGN Position: Q1 2026 in Review

Cresset Asset Management reduced its Amgen (AMGN) stake by 1.1% in Q1 2026, selling an estimated $178K and leaving 45,854 shares worth $16.1M. The position accounts for 0.07% of the portfolio, ranked #185.

Cresset Asset Management first reported a position in AMGN in Q4 2018 and has held it in 30 quarters since. The position peaked at $27.4M in Q3 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Cresset Asset Management held 45,854 shares of Amgen worth $16.1M as of Q1 2026.
  • Cresset Asset Management sold 500 Amgen shares in Q1 2026, an estimated $178K.
  • Amgen made up 0.07% of Cresset Asset Management's portfolio in Q1 2026, its #185 holding.
  • Cresset Asset Management first reported a position in Amgen in Q4 2018 and has held it in 30 quarters since.
  • Cresset Asset Management's Amgen position peaked at $27.4M in Q3 2024.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Cresset Asset Management's 13F filing for Q1 2026, filed 15 May 2026.